LeadIQ logo
Learn more at LeadIQ.com

Insights

Funding Success Mission Therapeutics has secured significant funding, including a recent $32.3 million in Series D funding and a total of £87 million in venture capital, indicating financial stability and potential investment opportunities.

Therapeutic Focus With a focus on developing therapeutics for Parkinson's disease, mitochondrial diseases, fibrosis, and neurodegenerative disorders, Mission Therapeutics presents sales opportunities for pharmaceutical companies looking to collaborate or acquire innovative treatments in these areas.

Leadership Expansion Recent hires of key personnel like Dr. Thompson as CSO and Jonathan Hepple as Non-Executive Director highlight Mission Therapeutics’ commitment to strengthening its leadership team, potentially opening avenues for partnerships or collaborations with new executives.

Market Validation Influential organizations like Parkinson's UK's Virtual Biotech program, The Michael J. Fox Foundation, and Innovate UK have recognized Mission Therapeutics' work with grants and investments, providing validation that can enhance the company's credibility and attractiveness for partnerships.

Competitive Landscape Compared to similar companies like PhoreMost Ltd, Enterprise Therapeutics, and GammaDelta Therapeutics, Mission Therapeutics’ unique approach to targeting deubiquitylating enzymes (DUBs) sets it apart, positioning the company as an attractive partner for collaborations or acquisitions in the biotechnology sector.

Similar companies to Mission Therapeutics

Mission Therapeutics Tech Stack

Mission Therapeutics uses 8 technology products and services including Typekit, Twitter Emoji (Twemoji), Google Font API, and more. Explore Mission Therapeutics's tech stack below.

  • Typekit
    Font Scripts
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Google Font API
    Font Scripts
  • jQuery
    Javascript Libraries
  • Lightbox
    Javascript Libraries
  • HTTP/3
    Miscellaneous
  • YouTube
    Video Players
  • Twitter
    Widgets

Media & News

Mission Therapeutics's Email Address Formats

Mission Therapeutics uses at least 1 format(s):
Mission Therapeutics Email FormatsExamplePercentage
FLast@missiontherapeutics.comJDoe@missiontherapeutics.com
59%
First.Last@missiontherapeutics.comJohn.Doe@missiontherapeutics.com
24%
F.Last@missiontherapeutics.comJ.Doe@missiontherapeutics.com
9%
FirstL@missiontherapeutics.comJohnD@missiontherapeutics.com
8%

Frequently Asked Questions

Where is Mission Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Mission Therapeutics's main headquarters is located at Moneta, Building 280 Babraham Research Campus Cambridge, Cambs CB22 3AT GB. The company has employees across 2 continents, including EuropeNorth America.

What is Mission Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Mission Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Mission Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Mission Therapeutics's official website is missiontherapeutics.com and has social profiles on LinkedIn.

How much revenue does Mission Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Mission Therapeutics's annual revenue reached $3.8M.

What is Mission Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Mission Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Mission Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Mission Therapeutics has approximately 35 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: A. L.Chief Scientific Officer: C. J.Chief Financial Officer: D. L.. Explore Mission Therapeutics's employee directory with LeadIQ.

What industry does Mission Therapeutics belong to?

Minus sign iconPlus sign icon
Mission Therapeutics operates in the Biotechnology Research industry.

What technology does Mission Therapeutics use?

Minus sign iconPlus sign icon
Mission Therapeutics's tech stack includes TypekitTwitter Emoji (Twemoji)Google Font APIjQueryLightboxHTTP/3YouTubeTwitter.

What is Mission Therapeutics's email format?

Minus sign iconPlus sign icon
Mission Therapeutics's email format typically follows the pattern of . Find more Mission Therapeutics email formats with LeadIQ.

How much funding has Mission Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Mission Therapeutics has raised $5.2M in funding. The last funding round occurred on Jul 02, 2024 for $5.2M.

When was Mission Therapeutics founded?

Minus sign iconPlus sign icon
Mission Therapeutics was founded in 2011.
Mission Therapeutics

Mission Therapeutics

Biotechnology ResearchCambs, United Kingdom11-50 Employees

Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need.

Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’.

Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas.

Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially with a patient selection strategy to enhance the probability of demonstrating early signs of efficacy.

Mission’s leadership team has a wealth of international, commercial and scientific experience, and the company has strong links with key academic and research centers including Cancer Research UK Laboratories and the Jackson Laboratories at the Gurdon Institute, University of Cambridge.

The Company has to date received £87 million in venture capital from a blue chip syndicate comprising institutional and corporate investors and was awarded a £1.9 million grant from Innovate UK in September 2015.

In February 2016, the Company raised £60 million in a Series C financing led by Imperial Innovations and new investor Woodford Patient Capital Trust. It included follow-on investment from existing shareholders Sofinnova Partners, SR One, Roche Venture Fund and Pfizer Venture Investments. Mission is based at the Babraham Research Campus, south of Cambridge.

Section iconCompany Overview

Headquarters
Moneta, Building 280 Babraham Research Campus Cambridge, Cambs CB22 3AT GB
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
11-50

Section iconFunding & Financials

  • $5.2M

    Mission Therapeutics has raised a total of $5.2M of funding over 9 rounds. Their latest funding round was raised on Jul 02, 2024 in the amount of $5.2M.

  • $10M

    Mission Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $5.2M

    Mission Therapeutics has raised a total of $5.2M of funding over 9 rounds. Their latest funding round was raised on Jul 02, 2024 in the amount of $5.2M.

  • $10M

    Mission Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.